BRITTNEY WILLIAMS: Open Payments
NPI 1689457806 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 91 payments from 12 companies in 2025. Trend: 2023 $170 · 2024 $845 · 2025 $1,762
Food & beverage: $1,762
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $719 |
| Janssen Biotech, Inc. | 12 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $233 |
| Ardelyx, Inc. | 10 | $231 |
| PFIZER INC. | 6 | $109 |
| Phathom Pharmaceuticals, Inc. | 4 | $44 |
| EVOKE PHARMA, INC. | 2 | $44 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| GENZYME CORPORATION | 1 | $35 |
| Gilead Sciences, Inc. | 2 | $33 |
Products named: RINVOQ, TREMFYA, IBSRELA, LINZESS, ENTYVIO, CREON, SKYRIZI, XELJANZ.
Industry payments across GA — which companies pay providers there.
